Mobile Solutions for a Health-Secure Future
Testing Center and Laboratory Mobile Pods
Complete turnkey solution with sample collection, Antigen POC LFA and PCR testing facilities, fully equipped high complexity laboratory, and collaboration space for medical experts. 20’ and 40’ pods suitable for any location.
Temperature control with state-of-the-art air sanitizer, secure digital health app that integrates with existing platforms and provides health certification and back tracing. Honeywell crowd management technology. Optional solar panels.
OHS Mobile Pod Solutions are designed to expedite testing, screening, and eventually vaccination on massive scale to support a health-secure future.
Fast and Portable Mobile qPCR Solution
Battery-operated for maximum portability enabling a full day’s work on a single charge.
Ruggedized, 9 and 16 well thermocyclers.
Portable, hand-held solution for remote work locations across U.S., Canada and internationally, weighing 3 lbs.
Real-time PCR analysis with results in under an hour.
Kit complete with tablet or mobile with cloud software for secure data handling.
Ready-to-Use Well Plates PCR Solution
Non-cold chain, ready-to-use 9, 16, 96 and 384 well plates
Desiccated pellets eliminate need for reagents and mixes. Ideal for remote geographies, is shelf-stable and allows expansion of testing centers.
3 preparation steps instead of typical 15
Minimizes pipette errors and possible contaminants. Sensitivity and specificity results at 100%.
Triplex with 3 gene channels per tube
Works with fluorophores thermocyclers (ThermoFisher, Bio-Rad). FDA and Health Canada approved, and CE
Increase testing volume up to 30% marked.
Providing Key Diagnostic Testing Response Technology
FDA EUA Antigen POC Solution
Our FDA/EUA-approved Antigen POC Solution provides results in 10 minutes with 88.4% sensitivity and 100% specificity.
Antigen lateral flow assay cassette test
FDA EUA approved CE Marked
Results in 10 minutes with less than 12% false-negatives and 0% false-positives.
Immediate volume available, despite 26-million-unit backlog
CE Marked Antigen POC Solution
Upcoming - Rapid Digital Saliva Test
CE Marking estimated March 1, 2021.
Not yet authorized by the FDA; undergoing FDA EUA process and subject to such regulatory approval.
In-country manufacturing and strategic alliance potential.
Contact us today to learn more about our leading technologies!